Furthermore, positive CCL5 expression in the IC was associated with shorter DSS in the following subgroups: tumor stage pT3 + 4 (p = 0.003), N0 (p = 0.037), NX (p = 0.035), and no chemotherapy (p < 0.001). The gene discussed is CCL5; the disease is neoplasm.